Literature DB >> 14729970

E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice.

David B Sykes1, Mark P Kamps.   

Abstract

Oncoprotein E2a/Pbx1 is produced by the t(1;19) chromosomal translocation of human pre-B acute lymphoblastic leukemia. E2a/Pbx1 blocks differentiation of primary myeloid progenitors but, paradoxically, induces apoptosis in established pre-B-cell lines, and no transforming function of E2a/Pbx1 has been reported in cultured lymphoid progenitors. Here, we demonstrate that E2a/Pbx1 induces immortal proliferation of stem cell factor (SCF)-dependent pro-T thymocytes by a mechanism dependent upon both its transactivation and DNA-binding functions. E2a-Pbx1 cooperated with cytokines or activated signaling oncoproteins to induce cell division, as inactivation of conditional E2a/Pbx1 in either factor-dependent pro-T cells or pro-T cells made factor independent by expression of Bcr/Abl resulted in pro-T-cell quiescence, while reactivation of E2a/Pbx1 restored cell division. Infusion of E2a/Pbx1 pro-T cells in mice caused T lymphoblastic leukemia and, unexpectedly, acute myeloid leukemia. The acute lymphoblastic leukemia did not evidence further maturation, suggesting that E2a/Pbx1 establishes an early block in pro-T-cell development that cannot be overcome by marrow or thymic microenvironments. In an E2a/Pbx1 pro-T thymocyte clone that induced only pro-T acute lymphoblastic leukemia, coexpression of Bcr/Abl expanded its leukemic phenotype to include acute myeloid leukemia, suggesting that unique functions of cooperating signaling oncoproteins can influence the lymphoid versus myeloid character of E2a/Pbx1 leukemia and may cooperate with E2a/Pbx1 to dictate the pre-B-cell phenotype of human leukemia containing t(1;19).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729970      PMCID: PMC321418          DOI: 10.1128/MCB.24.3.1256-1269.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  Immortalized hemopoietic cells with stem cell properties.

Authors:  P M Wong; X D Han; F W Ruscetti; S W Chung
Journal:  Immunity       Date:  1994-10       Impact factor: 31.745

2.  A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression.

Authors:  D I Godfrey; J Kennedy; T Suda; A Zlotnik
Journal:  J Immunol       Date:  1993-05-15       Impact factor: 5.422

3.  Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development.

Authors:  S Tsai; S Bartelmez; E Sitnicka; S Collins
Journal:  Genes Dev       Date:  1994-12-01       Impact factor: 11.361

4.  Detection of BCR-ABL and E2A-PBX1 fusion genes by RT-PCR in acute lymphoblastic leukaemia with failed or normal cytogenetics.

Authors:  P E Devaraj; L Foroni; V Kitra-Roussos; L M Secker-Walker
Journal:  Br J Haematol       Date:  1995-02       Impact factor: 6.998

5.  Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable.

Authors:  K Monica; D P LeBrun; D A Dedera; R Brown; M L Cleary
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

6.  Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice.

Authors:  D A Dedera; E K Waller; D P LeBrun; A Sen-Majumdar; M E Stevens; G S Barsh; M L Cleary
Journal:  Cell       Date:  1993-09-10       Impact factor: 41.582

7.  Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence.

Authors:  M P Kamps; D D Wright
Journal:  Oncogene       Date:  1994-11       Impact factor: 9.867

8.  Dominant interfering alleles define a role for c-Myb in T-cell development.

Authors:  P Badiani; P Corbella; D Kioussis; J Marvel; K Weston
Journal:  Genes Dev       Date:  1994-04-01       Impact factor: 11.361

9.  Heterogeneity of t(1;19)(q23;p13) acute leukaemias. French Haematological Cytology Group.

Authors:  X Troussard; R Rimokh; F Valensi; D Leboeuf; O Fenneteau; A M Guitard; A M Manel; F Schillinger; C Leglise; A Brizard
Journal:  Br J Haematol       Date:  1995-03       Impact factor: 6.998

10.  Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.

Authors:  J J Peschon; P J Morrissey; K H Grabstein; F J Ramsdell; E Maraskovsky; B C Gliniak; L S Park; S F Ziegler; D E Williams; C B Ware; J D Meyer; B L Davison
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

View more
  12 in total

1.  Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis.

Authors:  Yan Liu; Xiaofeng Xu; Peng Lin; Yuanming He; Yawen Zhang; Biyin Cao; Zubin Zhang; Gautam Sethi; Jinbao Liu; Xiumin Zhou; Xinliang Mao
Journal:  J Biol Chem       Date:  2019-02-04       Impact factor: 5.157

2.  Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes.

Authors:  Gang G Wang; Martina P Pasillas; Mark P Kamps
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

Review 3.  Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers.

Authors:  Ping Chi; C David Allis; Gang Greg Wang
Journal:  Nat Rev Cancer       Date:  2010-07       Impact factor: 60.716

4.  High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia.

Authors:  Janet Bijl; Martin Sauvageau; Alexander Thompson; Guy Sauvageau
Journal:  Genes Dev       Date:  2005-01-15       Impact factor: 11.361

5.  Underexpression of LINC00173 in TCF3/PBX1-Positive Cases Is Associated With Poor Prognosis in Children With B-Cell Precursor Acute Lymphoblastic Leukemia.

Authors:  Didier Ismael May-Hau; Diego Alberto Bárcenas-López; Juan Carlos Núñez-Enríquez; Vilma Carolina Bekker-Méndez; Fredy Omar Beltrán-Anaya; Elva Jiménez-Hernández; Mónica Patricia Ortíz-Maganda; Francisco Xavier Guerra-Castillo; Aurora Medina-Sanson; Janet Flores-Lujano; Jorge Alfonso Martín-Trejo; José Gabriel Peñaloza-González; Martha Margarita Velázquez-Aviña; José Refugio Torres-Nava; Gabriela Alicia Hernández-Echáurregui; Rosa Martha Espinosa-Elizondo; María de Lourdes Gutiérrez-Rivera; Rodrigo Sanchez-Hernandez; María Luisa Pérez-Saldívar; Luz Victoria Flores-Villegas; Laura Elizabeth Merino-Pasaye; David Aldebarán Duarte-Rodríguez; Minerva Mata-Rocha; Omar Alejandro Sepúlveda-Robles; Haydeé Rosas-Vargas; Alfredo Hidalgo-Miranda; Juan Manuel Mejía-Aranguré; Silvia Jiménez-Morales
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

6.  Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9.

Authors:  Hiroyuki Kawagoe; Gerard C Grosveld
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

7.  Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus.

Authors:  Gang G Wang; Martina P Pasillas; Mark P Kamps
Journal:  Blood       Date:  2005-03-08       Impact factor: 22.113

8.  A novel unbalanced de novo translocation der(5)t(4;5)(q26;q21.1) in adult T-cell precursor lymphoblastic leukemia.

Authors:  Eigil Kjeldsen; Anne Stidsholt Roug
Journal:  Mol Cytogenet       Date:  2012-05-01       Impact factor: 2.009

Review 9.  PBX1: a key character of the hallmarks of cancer.

Authors:  Rafaela Nasser Veiga; Jaqueline Carvalho de Oliveira; Daniela Fiori Gradia
Journal:  J Mol Med (Berl)       Date:  2021-09-16       Impact factor: 4.599

10.  Retrovirus-Mediated Expression of E2A-PBX1 Blocks Lymphoid Fate but Permits Retention of Myeloid Potential in Early Hematopoietic Progenitors.

Authors:  Mark W Woodcroft; Kyster Nanan; Patrick Thompson; Kathrin Tyryshkin; Steven P Smith; Robert K Slany; David P LeBrun
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.